Loading...
Docoh
Log in Free sign up

Inari Medical (NARI)

News

From Benzinga Pro
Inari Medical's Return On Capital Employed Insights
23 May 22
Earnings
Benzinga Pro data, Inari Medical (NASDAQ:NARI) reported Q1 sales of $86.75 million. Earnings fell to a loss of $3.13 million, resulting in a 382.66% decrease from last quarter.
Inari Medical Q1 Earnings Beat Street View, Lifts FY22 Sales Outlook Above Consensus
5 May 22
Earnings, News, Guidance, Health Care, Movers, Trading Ideas, General
Inari Medical Q1 EPS $(0.06) Beats $(0.09) Estimate, Sales $86.80M Beat $83.61M Estimate
4 May 22
Earnings, News
Inari Medical (NASDAQ:NARI) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.09) by 33.33 percent. This is a 146.15 percent decrease over earnings of $0.13 per share from
Earnings Scheduled For May 4, 2022
4 May 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
A Preview Of Inari Medical's Earnings
3 May 22
Earnings
Inari Medical (NASDAQ:NARI) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Inari Medical will report an earnings per share (EPS) of $-0.09.
Inari Medical Set to Join S&P MidCap 400, To Replace Tri Pointe Homes; Tri Point Homes To Join S&P SmallCap600, To Replace US Ecology
28 Apr 22
News
https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20220428-1452108/1452108_6ecol.pdf
Canaccord Genuity Maintains Buy on Inari Medical, Lowers Price Target to $96
14 Mar 22
News, Price Target, Analyst Ratings
Canaccord Genuity analyst William Plovanic maintains Inari Medical (NASDAQ:NARI) with a Buy and lowers the price target from $102 to $96.

Press releases

From Benzinga Pro
Inari Medical Announces Launch of 2021 Ethos and Sustainability Report
13 May 22
Analyst Ratings, Press Releases
IRVINE, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
Inari Medical Reports First Quarter 2022 Financial Results
4 May 22
Earnings, Press Releases
IRVINE, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
Inari Medical Set to Join S&P MidCap 400; Tri Pointe Homes to Join S&P SmallCap 600
28 Apr 22
Press Releases
NEW YORK, April 28, 2022 /PRNewswire/ -- Inari Medical Inc. (NASD:NARI) will replace Tri Pointe Homes Inc. (NYSE:TPH) in the S&P MidCap 400, and Tri Pointe Homes will replace US Ecology Inc. (NASD:ECOL) in the
Inari Medical to Present at the Bank of America 2022 Healthcare Conference
28 Apr 22
News, Health Care, Press Releases
IRVINE, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous diseases,
Inari Medical to Announce First Quarter 2022 Financial Results
20 Apr 22
News, Press Releases
IRVINE, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
Inari Medical Announces Closing of Underwriters' Over-Allotment Option in Connection with Offering of Common Stock
21 Mar 22
Press Releases
IRVINE, Calif., March 21, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
Inari Medical Announces Pricing of Offering of Common Stock
10 Mar 22
News, Financing, Markets, Press Releases
IRVINE, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous
Inari Medical Announces Proposed Offering of Common Stock
10 Mar 22
Markets, Press Releases
IRVINE, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous